Related Experiment Video

Updated: Jun 16, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

Dysthymia before myocardial infarction as a cardiac risk factor at 2.5-year follow-up

Chiara Rafanelli1, Yuri Milaneschi, Renzo Roncuzzi

  • 1Dept. of Psychology, University of Bologna, Viale Berti Pichat, 5, 40127 Bologna, Italy. chiara.rafanelli@unibo.it

Psychosomatics
|February 2, 2010
PubMed

Insights

Previous dysthymia, a form of chronic depression, was linked to poorer cardiac outcomes in patients following coronary heart disease (CHD). Further research is needed to find effective treatments for dysthymic patients with CHD.

Area of Science:

  • Cardiology
  • Psychiatry
  • Psychosomatic Medicine

Background:

  • The impact of prior depression on the prognosis of coronary heart disease (CHD) remains understudied.
  • Understanding this relationship is crucial for developing effective treatment strategies for cardiac patients.

Purpose of the Study:

  • To investigate the association between pre-existing depression (major/minor depression, dysthymia, demoralization) and cardiac outcomes.
  • To assess cardiac prognosis at 2.5-year follow-up in patients with acute coronary heart disease (CHD).

Main Methods:

  • 97 consecutive patients admitted with acute CHD were studied during remission.
  • Mood disorders preceding the first CHD event were assessed at baseline and 2.5-year follow-up using various depression measures.

Main Results:

  • Dysthymia was the only depression measure significantly associated with poor cardiac outcome.
  • Other forms of depression and demoralization did not show a statistically significant link to cardiac prognosis in this cohort.

Conclusions:

  • Dysthymia may represent a significant risk factor for adverse cardiac outcomes post-myocardial infarction or angina.
  • Targeted research is necessary to develop and evaluate treatments for dysthymia in patients with coronary heart disease.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...